2m 2m 2m 2m 2m 2m 2m
APOGEE THERAP (APGE)
NASDAQ
$134.83+$0.07 (+0.06%)
Price as of Aug 21, 2026 7:30 PM EDT- $8.4BMarket Cap
- 252.10%1-Year Change
- BiotechnologyIndustry
APOGEE THERAP (APGE)
$134.83+$0.07 (+0.06%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VR ADVISER, LLC | 13.73% | 8.5M | 0 (0.00%) | Jun 30, 2026 |
BLACKROCK, INC. | 8.90% | 5.5M | +1.4M (+25.81%) | Jun 30, 2026 |
BLACKROCK FUNDING, INC. /DE | 4.92% | 3.0M | +69,041 (+2.27%) | Dec 31, 2024 |
VANGUARD GROUP INC | 4.62% | 2.9M | +612,193 (+21.42%) | Dec 31, 2025 |
HBK INVESTMENTS L P | 4.61% | 2.9M | +2.9M (+100.00%) | Jun 30, 2026 |
RTW INVESTMENTS, LP | 4.50% | 2.8M | +70,000 (+2.52%) | Mar 31, 2026 |
BLACKROCK INC. | 4.43% | 2.7M | -67,276 (-2.45%) | Jun 30, 2024 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIDELITY MT VERNON STREET TRUST | 4.71% | 2.9M | +209,208 (+7.18%) | May 31, 2026 |
VANGUARD SPECIALIZED FUNDS | 2.41% | 1.5M | -580,216 (-38.92%) | Apr 30, 2026 |
FIDELITY SECURITIES FUND | 2.08% | 1.3M | +167,813 (+13.05%) | Apr 30, 2026 |
VANGUARD EXPLORER FUND | 0.86% | 530,576 | 0 (0.00%) | Apr 30, 2026 |
Voya INVESTORS TRUST | 0.85% | 525,313 | +396,004 (+75.38%) | Mar 31, 2026 |
FIDELITY ADVISOR SERIES VII | 0.82% | 507,955 | +5,900 (+1.16%) | Apr 30, 2026 |
FIDELITY CONCORD STREET TRUST | 0.80% | 494,232 | +44,607 (+9.03%) | May 31, 2026 |
Current Ownership Distribution
- Institutions468.1M (88.50%)
- Mutual Funds59.1M (11.17%)
- Insiders1.7M (0.32%)
- Other0 (0.00%)
Insider Transactions
- 0.32% (1.7M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 4Number of InsiderSelling (last 12 months)
- $1.7BAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Fairmount Funds Management LLC | Exempt | Aug 07, 2026 | $0.00 | 31,838 | $0.00 | 0 |
Fairmount Funds Management LLC | Exempt | Aug 07, 2026 | $0.00 | 10,370 | $0.00 | 0 |
Fairmount Funds Management LLC | Exempt | Aug 07, 2026 | $541,246.00 | 31,838 | $17.00 | 330,485 |
Fairmount Funds Management LLC | Exempt | Aug 07, 2026 | $454,724.50 | 10,370 | $43.85 | 340,855 |
Dambkowski Carl Chief Medical Officer | Exempt | Aug 05, 2026 | $0.00 | 4,125 | $0.00 | 110,665 |
Dambkowski Carl Chief Medical Officer | Exempt | Aug 05, 2026 | $94,297.50 | 4,125 | $22.86 | 173,998 |
Dambkowski Carl Chief Medical Officer | Sell | Aug 05, 2026 | $737,935.00 | 5,500 | $134.17 | 168,498 |
Dambkowski Carl Chief Medical Officer | Gift | Jul 14, 2026 | $0.00 | 8,000 | $0.00 | 169,873 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Gift | Jul 10, 2026 | $0.00 | 75,046 | $0.00 | 920,941 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jul 08, 2026 | $2.7M | 20,000 | $133.63 | 995,987 |
Dambkowski Carl Chief Medical Officer | Sell | Jun 22, 2026 | $3.5M | 26,400 | $132.60 | 179,248 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $556,561.70 | 6,770 | $82.21 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $633,598.12 | 7,654 | $82.78 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $90,914.40 | 1,080 | $84.18 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $134,344.63 | 1,577 | $85.19 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $198,852.35 | 2,305 | $86.27 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $53,350.46 | 614 | $86.89 | 1.1M |
Fairmount Funds Management LLC | Award | Jun 09, 2026 | $0.00 | 7,657 | $0.00 | 7,657 |
Bollinger Lisa | Award | Jun 09, 2026 | $0.00 | 7,657 | $0.00 | 7,657 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Apr 08, 2026 | $1.5M | 17,800 | $82.48 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Apr 08, 2026 | $166,520.00 | 2,000 | $83.26 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Apr 08, 2026 | $17,000.00 | 200 | $85.00 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Mar 11, 2026 | $621,287.27 | 8,363 | $74.29 | 1.2M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Mar 11, 2026 | $615,027.77 | 8,219 | $74.83 | 1.2M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Mar 11, 2026 | $259,289.48 | 3,418 | $75.86 | 1.2M |
Dambkowski Carl Chief Medical Officer | Exempt | Mar 04, 2026 | $0.00 | 4,125 | $0.00 | 131,290 |
Dambkowski Carl Chief Medical Officer | Exempt | Mar 04, 2026 | $94,297.50 | 4,125 | $22.86 | 215,273 |
Dambkowski Carl Chief Medical Officer | Sell | Mar 04, 2026 | $226,814.25 | 3,225 | $70.33 | 212,048 |
Dambkowski Carl Chief Medical Officer | Sell | Mar 04, 2026 | $149,358.50 | 2,075 | $71.98 | 209,973 |
Dambkowski Carl Chief Medical Officer | Sell | Mar 04, 2026 | $14,652.00 | 200 | $73.26 | 209,773 |